This inventor holds 1 USPTO granted patent. Top assignee: Taimed Biologics, Inc.. Active years: 2014.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2014
Title: Réjean Ruel: Innovator in HIV Research
Introduction
Réjean Ruel is a notable inventor based in St. Lambert, Canada. He has made significant contributions to the field of pharmaceutical sciences, particularly in the development of compounds aimed at combating HIV.
Latest Patents
Ruel holds a patent for "HIV integrase inhibitors from pyridoxine." This invention relates to pyridoxine (vitamin B) derived compounds that inhibit the Human Immunodeficiency Virus (HIV)-integrase enzyme. The compounds are useful for preventing and treating HIV infection and AIDS. His patent includes pharmaceutically acceptable salts or solvates of the compounds, which are defined in the specification.
Career Highlights
Ruel is associated with Taimed Biologics, Inc., where he continues to work on innovative solutions for health challenges. His research focuses on the development of effective treatments for viral infections, showcasing his commitment to improving public health.
Collaborations
Some of his notable coworkers include Brent Richard Stranix and Francis Beaulieu, who contribute to the collaborative efforts in research and development at Taimed Biologics, Inc.
Conclusion
Réjean Ruel's work in developing HIV integrase inhibitors highlights his dedication to advancing medical science. His contributions are vital in the ongoing fight against HIV and AIDS, making a significant impact in the field of pharmaceuticals.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile